REGINA FONG: Open Payments
NPI 1285017236 · NEW HYDE PARK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,967 in 110 payments from 15 companies in 2025. Trend: 2023 $983 · 2024 $1,499 · 2025 $1,967
Food & beverage: $1,967
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $474 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 25 | $375 |
| E.R. Squibb & Sons, L.L.C. | 9 | $221 |
| Vanda Pharmaceuticals Inc. | 16 | $218 |
| Axsome Therapeutics, Inc. | 12 | $193 |
| Janssen Pharmaceuticals, Inc | 3 | $96 |
| Lundbeck LLC | 5 | $89 |
| Alkermes, Inc. | 2 | $63 |
| Indivior Inc. | 2 | $55 |
| Supernus Pharmaceuticals, Inc. | 3 | $55 |
Products named: VRAYLAR, CAPLYTA, COBENFY, Auvelity, FANAPT, SPRAVATO, REXULTI, ARISTADA.
Industry payments across NY — which companies pay providers there.
